Healthcare Technology
News Category
Vinmec Launches Vietnam's First Integrated High-Tech Robotic Surgery Network, Establishing Multi-Connected Robotic Surgery Ecosystem
Vinmec Healthcare System launches Vietnam's first integrated high-tech robotic surgery network, connecting multiple specialties and hospitals to expan...
HeartBeam Reorganizes to Accelerate Global Commercialization of 3D ECG Technology
HeartBeam (BEAT) announced a strategic reorganization to accelerate global commercialization of its patented 3D ECG platform, with a focus on expandin...
HeartBeam Launches Pilot Study to Test On-Demand 12-Lead ECG Patch for Ischemia Detection
HeartBeam's new pilot study evaluates a proprietary patch that generates on-demand 12-lead ECGs, potentially disrupting the $2 billion ambulatory moni...
Accelerometer Medical Sensors Market to Reach USD 25.7 Billion by 2036 as Remote Monitoring and Wearable Healthcare Technologies Accelerate Adoption
The global accelerometer medical sensors market is projected to grow from USD 7.0 billion in 2026 to USD 25.7 billion by 2036 at a CAGR of 13.9%, driv...
Smartphone Apps and Wearables Boost Physical Activity in Heart Disease Patients, Study Finds
A meta-analysis published in the Journal of the American Heart Association reveals that digital tools like smartphone apps and fitness trackers help p...
SS Innovations Completes World-Record 12,500-Mile Robotic Cardiac Telesurgery
SS Innovations International achieved a record-breaking 12,500-mile robotic cardiac telesurgery, demonstrating the capabilities of its SSi Mantra syst...
HeartBeam Study Validates Portable ECG Device for Heart Attack Risk Assessment
A peer-reviewed study published in JACC: Advances shows that HeartBeam's credit card-sized ECG device, combined with a risk algorithm, can accurately ...
AI-Powered Wearables Transform Patient Monitoring and Clinical Decision-Making
Advances in AI and edge computing are turning healthcare wearables into clinical tools that provide real-time, actionable insights, improving patient ...
HeartBeam Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
A peer-reviewed study published in JACC: Advances demonstrates that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorith...
LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. (OTC: LMED) will attend MEDICA 2026 in Dusseldorf, Germany, to advance its telehealth and AI-driven healthcare platform for emerging ...
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG Technology
HeartBeam is developing a cable-free, portable 12-lead ECG system to address pre-hospital delays in cardiac care by enabling patients to record clinic...
Smart Wristband Shows Promise in Detecting Cardiac Arrest, Study Finds
A new study published in Circulation: Arrhythmia and Electrophysiology found that a smart wristband using a photoplethysmography algorithm accurately ...
American Heart Association Launches Initiative to Close Technology Gaps in Cardiac and Stroke Emergency Response
The American Heart Association, with support from T-Mobile, is launching an initiative to identify and address communication and technology gaps in em...
LogicMark's AI-Driven Personal Safety Technology Reshapes Aging in Place
LogicMark's AI-powered connected care ecosystem, including predictive digital twin technology and blockchain-based privacy, is evolving personal emerg...
HeartBeam Reports First-Quarter 2026 Results, Advances Commercial Launch of Cardiac Monitoring Platform
HeartBeam reported a narrower Q1 2026 net loss of $4.7 million and highlighted the launch of initial commercial partnerships in key U.S. markets, prog...
MindBio Therapeutics AI Voice Analysis Platform Featured in BioMedWire Editorial on Real-Time Intoxication Detection
MindBio Therapeutics' AI-driven voice analysis platform for detecting drug and alcohol intoxication is highlighted in a BioMedWire editorial, emphasiz...
SS Innovations Successfully Demonstrates Long-Distance Telesurgery Across 4,500 Miles
SS Innovations performed a landmark telesurgery from Australia to India using its SSi Mantra surgical robotic system, highlighting the potential to de...
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology
MindBio Therapeutics Corp. announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, to be added to its Edg...
Voice Analysis and AI Could Revolutionize Intoxication Detection, MindBio Therapeutics Advances Noninvasive Platform
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol intoxication in real-time from short speech sample...
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection Amid Growing Real-Time Diagnostics Market
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safe...
Aclarion Expands Commercial Team with Inducement Grant to New Western U.S. Director
Aclarion grants stock options to new Commercial Director Daniel Keefe to support growing demand for its Nociscan platform, which uses AI to identify p...
HeartBeam Targets Heart Disease with Next-Generation ECG Technology to Reduce Patient Delay in Seeking Care
HeartBeam Inc. is addressing the leading cause of death in the U.S. by developing advanced ECG solutions designed to improve early detection and reduc...
Ventripoint to Showcase VMS+™ at AEPC 2026 Annual Meeting
Ventripoint will exhibit at the AEPC conference, highlighting how its VMS+™ 4.0 system provides MRI-equivalent cardiac measurements via echocardiograp...
Aclarion Reports 196% Annual Scan Volume Growth in Q1 2026, Signaling Accelerating Clinical Adoption of Nociscan
Aclarion's Q1 2026 results show 196% year-over-year scan volume growth, advancing Nociscan adoption, reimbursement progress, and a strong cash positio...
Ventripoint's VMS+ 4.0 Submitted for Regulatory Approval in China via Green Channel Pathway
Ventripoint Diagnostics announced that its strategic partner Lishman Global has submitted the VMS+ 4.0 AI-powered cardiac imaging system to China's NM...
Aclarion Appoints Daniel Keefe as Commercial Director for Western U.S. to Accelerate Nociscan Adoption
Aclarion hires Daniel Keefe to lead Western U.S. commercial efforts, capitalizing on triple-digit growth in Nociscan utilization for chronic low back ...
HeartBeam Collaborates with Mount Sinai to Advance AI-Driven ECG Technology
HeartBeam (BEAT) partners with Mount Sinai to develop AI-based ECG algorithms, enhancing remote cardiac monitoring and data-driven healthcare solution...
Cardio Diagnostics' AI Platform Advances Personalized Heart Health Assessment
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) leverages artificial intelligence to integrate multi-omic data from a simple blood draw, offering pers...
HeartBeam Collaborates with Mount Sinai to Advance AI-Powered ECG Technology
HeartBeam Inc. announced a strategic collaboration with Mount Sinai to develop and validate AI-based ECG algorithms, aiming to enhance remote cardiac ...
SS Innovations Debuts Drone, Humanoid, and Mobile OR Surgical Robots at SMRSC 2026
SS Innovations unveiled several cutting-edge surgical robotic technologies at SMRSC 2026, including a drone-deployed surgical robot, a humanoid surgic...
Cardio Diagnostics Holdings (CDIO) Gains Attention for AI-Driven Cardiovascular Disease Management
Cardio Diagnostics Holdings (NASDAQ: CDIO) is highlighted for its AI-powered precision medicine approach that integrates epigenetics, genetics, and ar...
HeartBeam Closes $10M Public Offering to Advance Cardiac Technology Commercialization
HeartBeam's $10 million public offering will fund commercialization of its FDA-cleared 12-lead synthesized ECG system and development of extended-wear...
Cardio Diagnostics Holdings: AI-Powered Precision in Cardiovascular Care
Cardio Diagnostics Holdings uses AI, epigenetics, and genetics to transform cardiovascular disease prevention, detection, and management, offering a m...
HeartBeam Closes $10 Million Public Offering to Advance Cardiac Technology Commercialization
HeartBeam Inc. raised $10 million through a public offering to fund the commercialization of its FDA-cleared 12-lead synthesized ECG system and develo...
Aclarion Secures U.S. Patent for AI-Driven Chronic Low Back Pain Assessment, Strengthening IP Portfolio and Scalability
Aclarion received a U.S. patent covering machine learning-based analysis of MRS data for chronic low back pain, which protects its AI-driven platform ...
Aclarion Wins Pinnacle Award for AI Innovation in Clinical Decision-Making for Chronic Low Back Pain
Aclarion received the Diamond Pinnacle Award for AI Innovation, following a 2025 HLTH Digital Health Award, recognizing its Nociscan platform that use...
Catalyst Crew Technologies Unveils PulmoAI for AI-Powered Lung Disease Detection
Catalyst Crew Technologies announced PulmoAI, an AI module for detecting and predicting pulmonary diseases, aiming to expand respiratory diagnostics i...
Aclarion Reports Nearly 100 Nociscan Procedures at The London Clinic, Signaling Growing Adoption
Aclarion announces that nearly 100 Nociscan procedures have been performed at The London Clinic, highlighting increased physician adoption and integra...
TibaRay Opens Wefunder Campaign for FLASH Radiotherapy Technology
TibaRay launches a Regulation CF campaign on Wefunder, enabling individual investors to support its next-generation accelerator technology designed to...
HeartBeam Inc.’s FDA Clearance and Analyst Upgrade Signal Commercial Transition
HeartBeam Inc. received FDA clearance for its 12-lead ECG synthesis software in December 2025, leading to an analyst upgrade from Hold to Buy with a r...
CardioDialysis: A Next-Generation Technology to Reduce Major Adverse Cardiovascular Events
Sigyn Therapeutics announces CardioDialysis, a single-device blood purification technology that integrates plasma separation and therapeutic adsorptio...
HeartBeam Partners With Mount Sinai to Accelerate AI-ECG Development and Validation
HeartBeam announced a collaboration with Mount Sinai to develop and validate AI-based ECG algorithms for cardiac monitoring, aiming to enhance remote ...
NextPlat Corp. Schedules Full-Year 2025 Earnings Release and Conference Call for March 31
NextPlat Corp. announced it will release its full-year 2025 financial results on March 31, 2026, with a conference call to follow, providing investors...
Catalyst Crew Technologies Seeks FINRA Approval for Rebrand to LataMed AI Corp.
Catalyst Crew Technologies has submitted a corporate action request to FINRA to change its name to LataMed AI Corp. and its trading symbol, reflecting...
Aclarion Adopts Limited Duration Stockholder Rights Plan to Protect Long-Term Value
Aclarion, Inc. announced a one-year stockholder rights plan to prevent hostile takeovers and ensure fair treatment of all shareholders.
Aclarion CEO Letter Highlights Reimbursement Push and CLARITY Trial Readout as Key 2026 Catalysts
Aclarion outlines strategic priorities for 2026, including pursuing U.S. insurance reimbursement and initial CLARITY trial results, supported by a str...
SS Innovations' SSi Mantra Robotic System Gets Nod for Telesurgeries in Indonesia and the Philippines
SS Innovations' SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines, with over 150 cumulative tele...
NeuroOne Announces Publication of Clinical Experience With Its OneRF sEEG-Guided Radiofrequency Ablation Technology
Peer-reviewed case series shows NeuroOne's OneRF Ablation System safely integrates into existing workflows, enables bedside treatment, and reduces sei...